Eiger BioPharmaceuticals, Inc. Quarterly Current Ratio in % from Q3 2014 to Q4 2023

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Eiger BioPharmaceuticals, Inc. quarterly Current Ratio history and growth rate from Q3 2014 to Q4 2023.
  • Eiger BioPharmaceuticals, Inc. Current Ratio for the quarter ending December 31, 2023 was 235 %, a 54.3% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q4 2023 235 -280 -54.3% Dec 31, 2023
Q3 2023 412 -68.8 -14.3% Sep 30, 2023
Q2 2023 465 +4.79 +1.04% Jun 30, 2023
Q1 2023 530 +81 +18.1% Mar 31, 2023
Q4 2022 515 -60.8 -10.6% Dec 31, 2022
Q3 2022 481 -249 -34.1% Sep 30, 2022
Q2 2022 460 -323 -41.3% Jun 30, 2022
Q1 2022 449 -302 -40.2% Mar 31, 2022
Q4 2021 576 -91.1 -13.7% Dec 31, 2021
Q3 2021 730 +121 +19.9% Sep 30, 2021
Q2 2021 783 +160 +25.6% Jun 30, 2021
Q1 2021 750 +46.3 +6.58% Mar 31, 2021
Q4 2020 667 -79.3 -10.6% Dec 31, 2020
Q3 2020 609 -242 -28.4% Sep 30, 2020
Q2 2020 624 -168 -21.2% Jun 30, 2020
Q1 2020 704 -46.6 -6.21% Mar 31, 2020
Q4 2019 746 +67.7 +9.98% Dec 31, 2019
Q3 2019 851 +279 +48.7% Sep 30, 2019
Q2 2019 791 +162 +25.8% Jun 30, 2019
Q1 2019 751 +180 +31.4% Mar 31, 2019
Q4 2018 678 -45.6 -6.29% Dec 31, 2018
Q3 2018 572 -306 -34.9% Sep 30, 2018
Q2 2018 629 -383 -37.8% Jun 30, 2018
Q1 2018 571 -649 -53.2% Mar 31, 2018
Q4 2017 724 -325 -31% Dec 31, 2017
Q3 2017 878 +184 +26.6% Sep 30, 2017
Q2 2017 1.01K +291 +40.5% Jun 30, 2017
Q1 2017 1.22K +752 +161% Mar 31, 2017
Q4 2016 1.05K +521 +98.7% Dec 31, 2016
Q3 2016 694 +13.7 +2.02% Sep 30, 2016
Q2 2016 720 -90.5 -11.2% Jun 30, 2016
Q1 2016 468 -1K -68.2% Mar 31, 2016
Q4 2015 528 -1.08K -67.3% Dec 31, 2015
Q3 2015 680 -495 -42.1% Sep 30, 2015
Q2 2015 810 Jun 30, 2015
Q1 2015 1.47K Mar 31, 2015
Q4 2014 1.61K Dec 31, 2014
Q3 2014 1.18K Sep 30, 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.